# Degludec Insulin Use in Critically Ill Patients

> **NCT06056167** · NA · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 155 (actual)

## Conditions studied

- Diabetes Mellitus
- Critical Illness
- Hyperglycemia

## Interventions

- **DRUG:** Degludec insulin

## Key facts

- **NCT ID:** NCT06056167
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-17
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06056167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06056167, "Degludec Insulin Use in Critically Ill Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06056167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*